Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RCT of hydromorphone vs fentanyl in continuous subcutaneous titration for severe cancer pain
jRCT1051220045Recruiting
- Start
- Jun 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial in cancer pain comparing Hydromorphone arm with Fentanyl arm (2 arms). Primary endpoint: Proportion of patients achieving at least 66% pain reduction within 3 days. Started Jun 2022; status: recruiting.
02
Drugs
hydromorphonefentanyl
03
Conditions
cancer pain
Beyond the preview
Go deeper on jRCT1051220045.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1051220045.